Andrew Stern

Andrew Stern

andrewmstern.bsky.social

Neurologist and Alzheimer disease scientist at Brigham and Women’s Hospital. My lab studies beta-amyloid aggregates as they occur in human brain. Also TDP-43 biomarkers. Associate PD for research at MGB neurology residency program. sternlab.bwh.harvard.edu

👤 Joined on 30 December 2023

741

Followers

578

Following

116

Total Posts

📜 Kullanıcı Geçmişi

  • 30 Ara 2023, 14:09
    🎉 Bluesky'e katıldı - İlk kullanıcı adı: @andrewmstern.bsky.social

❤️ Beğendiği Gönderiler

I agree. Oligomers have been a distraction for too long.

Show Post

Thank you Alzforum for highlighting our preprint! It's incredibly helpful to get the experts' feedback this early on in the publishing stage! www.alzforum.org/news/researc...

Show Post

Our newest paper studying immunosuppressive astrocyte-GBM interactions using RABID-seq is out in ‪@nature.com today! Congrats to Brian Andersen and Camilo Faust Akl! www.nature.com/articles/s41...

Show Post

Yes, it's multifactorial but I did find it interesting that your work suggests it's not per se the differences in CAA preference as you suggest. And to @drtfromkc.bsky.social - modified dosing does decrease ARIA. Donanemab increased ARIA in E3 but modified dose/escalation reduces it.

Show Post

Select language

Install App

Install App